Steve Salom

We raised a $40M Series A to build the automated lab for agentic biology. Last week, we shared the work we did with @Anthropic: Claude designed proteins, sent them to our automated wet lab, and got real experimental data back. We believe this is where biology is going: AI agents designing experiments, running them in automated wet labs, learning from the results and iterating. But AI can only move as fast as the experiments behind it. To use the potential of AI to cure all diseases, we need to build high-throughput wet lab infrastructure: a “biological gigafactory”. That’s exactly what we’re doing at Adaptyv. Over the past year we’ve grown our lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like @chaidiscovery and @boltz_bio to pharmas like @Roche and @novonordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.